Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists

Details for Australian Patent Application No. 2006270039 (hide)

Owner Azevan Pharmaceuticals, Inc.

Inventors Koppel, Gary A.; Miller, Marvin J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006270039

PCT Pub. Number WO2007/011878

Priority 60/700,673 19.07.05 US

Filing date 18 July 2006

Wipo publication date 25 January 2007

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/011878 Priority application(s): WO2007/011878

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006270040-Accommodating intraocular lens and methods of use

2006270038-Composition, method and apparatus for controlling pH and algae growth in water